PLSE - צמיחת הכנסות ב-12 חודשים נגררים Pulse Medical

The year-over-year sales volume growth trajectory for the rolling year demonstrates that the latest parameter for Pulse Biosciences, Inc. (PLSE) is 1643.60. This trend reflects the outsourcing of prototype assembly to external CMO plants under strict patent control. Success is based on FDA approvals and the adoption rates of Nano-Pulse. Meanwhile, business scaling is moderately dependent on clinic budgets and the overall state of the economy.
pulsebiosciences.com (PLSE) - פילוחי מדדים ודוחות פיננסיים

Pulse Biosciences, Inc. (PLSE) focuses on the commercialization of bioelectric ablation in cardiac surgery and dermatology, making revenue dynamics a critical marker of market adoption for the technology. By analyzing the TTM revenue growth trajectory compared to the previous year, an investor assesses the percentage change in total revenue over the trailing 12 months, separating sustainable organic growth from one-off factors to determine the asset's long-term investment attractiveness.